Use Able AI chat for product recommendations

ANKRD53 Polyclonal antibody

ANKRD53 Polyclonal Antibody for WB, IHC, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, ELISA

ankyrin repeat domain 53, Ankyrin repeat domain-containing protein 53

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for ANKRD53 in ?

Tested Applications

Positive WB detected inHeLa cells, HepG2 cells
Positive IHC detected inhuman rectal cancer tissue, mouse stomach tissue, mouse testis tissue, rat stomach tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:500-1:2000
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

24283-1-AP targets ANKRD53 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag15030

Product name: Recombinant human ANKRD53 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-343 aa of BC035234

Sequence: MASAGSTARRAGSGSWHSERGEGRGARPQPTPSGSMQQANKVSLKATWTDAESKQPSQPLPDLADHLSAQATALARPRRPASLTPPRADPSPSKESDQTAIDQTAIGSYYQLFAAAVGNVEWLRFCLNQSLREIPTDDKGFTAIHFAAQWGKIACLQVLVEEYKFPVDLLTNNSQTPLHLVIHRDNTTVALPCIYYLLEKGADLNAQTCNGSTPLHLAARDGLLDCVKVLVQSGANVHAQDAMGYKPIDFCKIWNHRACARFLKDAMWKKDKKDFAREMTKMKMFKSQLTLMEHNYLIEYQGQGCSVHFPFAFSPITPETLLWQDISLLSDCGFLWRRRELSF

Predict reactive species
Full Name ankyrin repeat domain 53
Calculated Molecular Weight 530 aa, 60 kDa
Observed Molecular Weight 60-70 kDa
GenBank Accession NumberBC035234
Gene Symbol ANKRD53
Gene ID (NCBI) 79998
RRIDAB_2879470
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ8N9V6
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

ANKRD53 also termed as ankyrin repeat domain 53 is a 533 amino-acid protein,which contains three ANK repeats and belongs to ankyrin family. The function of ANKRD53 is still non-known and need to be further studied. Ankyrins are membrane adaptor molecules that play important roles in coupling integral membrane proteins to the spectrin-based cytoskeleton network.

Protocols

Product Specific Protocols
IF protocol for ANKRD53 antibody 24283-1-APDownload protocol
IHC protocol for ANKRD53 antibody 24283-1-APDownload protocol
WB protocol for ANKRD53 antibody 24283-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The ANKRD53 Polyclonal antibody (catalog #24283-1-AP) has 2 total citations. One appears in Molecular Metabolism (2026), studying ANKRD53 downregulation in human obesity and its role in coordinating lipolysis with mitochondrial oxidative metabolism in adipocytes, using Western blot. The other is in Discover Oncology (2024), an integrative analysis of ANKRD53's potential value in stomach adenocarcinoma. The associated research fields are metabolic research (obesity/adipocyte metabolism) and oncology (stomach cancer).

SpeciesApplicationTitle
humanWB

Mol Metab

ANKRD53 is downregulated in human obesity and coordinates lipolysis with mitochondrial oxidative metabolism in adipocytes.

Authors - Yingying Su
  • KD Validated
Human

Discov Oncol

Integrative analysis indicates the potential values of ANKRD53 in stomach adenocarcinoma

Authors - Chunjing Jin
Loading...
||
New chat

Able®

正在加载,请稍候...